Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies

Clinical trial NCT06652633 · RECRUITING

Trial details

NCT number: NCT06652633
Sponsor: Lakefront Biotherapeutics NV
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hematological Malignancies

Start date: 2024-09-09
Primary completion: 2039-07-01
Enrollment: 546

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.